0123 GMT - Xero's bull at Macquarie says shares in the accounting-software provider are fundamentally mispriced, with the company's U.S. growth at an inflection point. A note from one of the investment bank's analysts points out that organic U.S. growth is accelerating, while its bill-pay unit is also showing strong momentum. This is being delivered with minimal go-to-market integration and ahead of Xero's planned U.S. brand investment. The analyst believes that AI distribution partnerships present upside, with adoption metrics already validating this narrative. Macquarie raises its target price 5.5% to A$235.80 and keeps an outperform rating on the stock, which is up 9.0% at A$80.29. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
May 14, 2026 21:23 ET (01:23 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.